Home » Topics » Regulatory

Regulatory
RSS

MicardisPlus approved in E.U. for hypertension

May 28, 2002

New indication and low dose strength of Vivelle-Dot approved

May 27, 2002

Copaxone prefilled syringes launched in Canada

May 27, 2002

MitoExtra NDA amendment accepted for filing

May 27, 2002

New strengths of Adderall XR approved for ADHD

May 27, 2002

Zelapar NDA in Parkinson's disease accepted for filing

May 27, 2002

Remodulin approved for pulmonary arterial hypertension

May 24, 2002

FDA advisory committee supports efficacy of Prevnar in otitis media

May 23, 2002

Low-dose formulation of Retin-A Micro approved by FDA

May 23, 2002

FDA approves Zoloft for premenstrual dysphoric disorder

May 22, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...